What did Amedisys Inc. pay for AseraCare Hospice?

Amedisys Inc. acquired AseraCare Hospice for $235.0M in 2020 (11.8x EBITDA), equivalent to 1.68x revenue. Target revenue was approximately $140.0M. Target EBITDA was approximately $20.0M.

What multiple did Amedisys Inc. pay for AseraCare Hospice?

11.8x EBITDA and 1.68x revenue, based on disclosed deal value of $235.0M and disclosed financials.

M&A TRANSACTION · 2020

AseraCare Hospice acquired by Amedisys Inc.

$235.0M· 11.8x EBITDA· 1.68x revenue

Target

AseraCare Hospice

Various

Regional hospice provider

Acquirer

Amedisys Inc.

Strategic buyer

Disclosed financials at time of acquisition

Revenue

$140.0M

EBITDA

$20.0M

Deal Value

$235.0M

EV/EBITDA

11.8x

Context

This $235.0M acquisition of AseraCare Hospice by Amedisys Inc. sits in the hospice sub-vertical. The 11.8x EBITDA multiple paid in 2020 can be compared against the population median for hospice transactions of similar size on our Hospice valuation hub. Amedisys Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price hospice businesses on our Hospice strategic buyer-pool page.

Source

Data sourced from Hospice News, Amedisys Press Release — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own hospice

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the AseraCare Hospice acquisition.

Citation: ExitValue.ai. (2020). AseraCare Hospice acquired by Amedisys Inc.. https://exitvalue.ai/deals/aseracare-hospice-acquired-by-amedisys-inc-home-healthc